(Q51553106)

7 April 2018

title

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women. (English)

1 reference

7 April 2018

0 references

1 reference

Teo SK

1

1 reference

7 April 2018

Scheffler MR

2

1 reference

7 April 2018

Kook KA

3

1 reference

7 April 2018

Tracewell WG

4

1 reference

7 April 2018

Colburn WA

5

1 reference

7 April 2018

Stirling DI

6

1 reference

7 April 2018

Thomas SD

7

1 reference

7 April 2018

publication date

1 January 2000

1 reference

7 April 2018

Biopharmaceutics and Drug Disposition

published in

1 reference

7 April 2018

volume

21

1 reference

7 April 2018

page(s)

33-40

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

Perspectives on the use of the baboon in embryology and teratology research

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Transit of pharmaceutical dosage forms through the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

The influence of food on the absorption of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Influence of food and fluid volume on chlorothiazide bioavailability: comparison of plasma and urinary excretion methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Food increases the bioavailability of isotretinoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Effect of meals on the kinetics of etretinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Plasma Concentrations of Digoxin after Oral Administration in the Fasting and Postprandial State

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Effects of Dietary Components on GI Absorption of Acetaminophen Tablets in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Thalidomide in painful AIDS-associated proctitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Thalidomide for the treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Bioavailability of erythromycin stearate: influence of food and fluid volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Enhancement of the bioavailability of propranolol and metoprolol by food

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28200001%2921%3A1%3C33%3A%3AAID-BDD213%3E3.0.CO%3B2-R

10.1002/1099-081X(200001)21:1<33::AID-BDD213>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

11038436

1 reference

7 April 2018